PET-demonstrated decreases in [C-11]flumazenil binding occur in anteri
or mesial temporal structures on the side of epileptogenesis in unilat
eral mesial temporal lobe epilepsy. We performed quantitative autoradi
ography on anterior mesial and lateral temporal specimens from 11 subj
ects with unilateral mesial temporal lobe epilepsy and six neurologica
lly normal controls to identify the predominant in vitro correlates of
the decreased [C-11]flumazenil binding. In anterior mesial temporal r
egions exhibiting the greatest neuronal cell loss, decreases in agonis
t and antagonist binding to type 1 and 2 (central) benzodiazepine bind
ing sites were highly correlated with neuronal cell counts. Cell loss
and decreased binding were particularly prominent in the lateral porti
on of hippocampal region CA1, adjacent to CA2. Lateral temporal centra
l benzodiazepine binding was diffusely increased, achieving statistica
l significance in cortical laminae V and VI. These findings suggest th
at the predominant source of PET-demonstrated decreases in [C-11]fluma
zenil binding in mesial temporal epilepsy is hippocampal sclerosis, ra
ther than downregulation of central benzodiazepine binding sites on su
rviving hippocampal neurone.